On June 16, 2025, China SXT Pharmaceuticals, Inc. reported the issuance of 90,000,000 new shares following the exercise of warrants by investors, resulting in a total of 116,027,758 shares outstanding as of June 10, 2025. This was part of a deal made on May 16, 2025, to sell 10 million shares at $0.51 each along with associated warrants.